China gave the greenlight to Eli Lilly & Co.’s blockbuster drug tirzepatide for use in treating diabetes, a move that will intensify the drugmaker’s rivalry with Novo Nordisk A/S over weight-loss drugs in the world’s second-largest market.... Read More
A Swiss-based drugmaker plans to double the size of its Indianapolis manufacturing plant, which produces nuclear medicine imaging and therapy products for cancer, in a move that would create 55 jobs with an average wage of $95,000.... Read More
Inside a large manufacturing building on the northwest side of Indianapolis, officials at Cardinal Health are busy at work on their latest expansion project, yet another clean room for nuclear medicine. Already, workers have erected massive walls of...... Read More
West Lafayette-based Inotiv Inc. is reporting a fiscal second quarter net loss of $48.1 million, compared to a loss of just under $10 million during the same period last year. The pharmaceutical testing company said Wednesday that it has also reached an...... Read More
Purdue University is looking to address what it calls an urgent need for accessible precision audiology in Indiana, particularly among underserved populations. The university said this month it will establish the Accessible Audiology Research Center at...... Read More
Eli Lilly and Co. has entered a settlement agreement with a South Carolina medical spa that was selling knockoff versions of its popular diabetes treatment Mounjaro and weight-loss treatment Zepbound. The agreement with Totality Medispa included an...... Read More
West Lafayette-based Inotiv Inc. is delaying its fiscal second quarter earnings report due to negotiations between the company and the U.S. Department of Justice. The pharmaceutical testing company says the move is related to an investigation that...... Read More
A biomedical researcher and entrepreneur whose innovations have helped improve treatment for people with musculoskeletal disorders has been named executive director of the Convergent Bioscience and Technology Institute at Indiana University Indianapolis.... Read More
16 Tech Community Corp. and Ivy Tech Community College are partnering to create a biopharmaceutical training center at the 16 Tech Innovation District. Supported by Eli Lilly and Co., the Ivy Tech Manufacturing Innovation Training Center is...... Read More
A Purdue University associate professor has received a $2.4 million grant from the National Institutes of Health to fight lung infections resistant to antimicrobial drugs. Qi “Tony” Zhou leads a team in developing inhalation treatments for lung infections. ... Read More
Indiana’s life sciences companies landed $5.5 billion in capital and investments last year from all sources, down 19% from a year earlier. That figure includes funds raised through venture capital and other sources, according to a report by BioCrossroads.... Read More
A medical device startup created by three University of Notre Dame graduate students took home nearly $130,000 in cash and in-kind services by winning the 2024 McCloskey New Venture Competition.... Read More
Eli Lilly and Co. said Tuesday that “exceptionally strong demand” for diabetes drugs Mounjaro and weight-loss drug Zepbound helped push first quarter profit up 67%, but warned that it expects tight supplies of both drugs to continue.... Read More
The student-led startup companies behind a stroke-treatment catheter, a meal-plan app and a makeup palette for the visually impaired received a combined $18,500 in cash prizes during the New Venture Challenge hosted by Purdue Innovates Incubator.... Read More
Buildings are starting to spring up at Eli Lilly and Co.’s construction site in Boone County, where the Indianapolis-based drugmaker is spending $3.7 billion to build a manufacturing campus to help turn out more medicines.... Read More
Indianapolis-based NICO Corp. recently wrapped up a large clinical trial that tested the company’s minimally invasive tools and technology for brain surgery in patients with hemorrhagic stroke. What NICO is doing is trying to shift the way surgeons treat...... Read More
Indianapolis-based Eli Lilly and Co. says its popular weight-loss treatment Zepbound showed potential to treat patients with obstructive sleep apnea in two late-stage clinical trials. Lilly shares rose 0.5%, to close at $750.77 each, after the announcement.... Read More
A new blood test being developed through a collaboration between Roche Diagnostics and Eli Lilly and Co. has been granted a breakthrough device designation by the U.S. Food and Drug Administration. The designation is intended to speed development and...... Read More
A life sciences startup founded by a Purdue University professor has been awarded a $275,000 National Science Foundation grant. Amplified Sciences is developing tests for early, more accurate detection of diseases, starting with pancreatic cancer.... Read More
If the toughest part of starting a new company is raising money, then Jay Shah and Vivek Ganesh have won plenty of believers with their new wearable epilepsy-monitoring device. Their company, Indianapolis-based Neurava Inc., raised $2.26 million in an...... Read More
